Evidence map›Paper›PMID 41630909›Full record

ArticleiScience2026

Centrosomal P4.1-associated protein is a novel regulator of ESCRT pathway function during endosome maturation.

Radhika Gudi, Chenthamarakshan Vasu

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Radhika GudiDepartment of Pharmacology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208E, Charleston, SC 29425, USA.
Chenthamarakshan VasuDepartment of Pharmacology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208E, Charleston, SC 29425, USA.

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
ESCRT-dependent novel regulatory mechanism of EMT and tumorigenesis in oral cancerR01DE030331 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Radhika Gudi, CHENTHAMARAKSHAN VASU · 2022 to 2026
$1.9M
A novel ESCRT-associated regulatory mechanism of EMT in oral cancerR21DE026965 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GUDI, RADHIKA, VASU, CHENTHAMARAKSHAN · 2017 to 2018
$598k
Confocal/Multiphoton Microscope UpgradeS10OD018113 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEMASTERS, JOHN J · 2015 to 2015
$570k
NCI NIH HHS P30 CA138313NIDCR NIH HHS R01 DE030331NIDCR NIH HHS R21 DE026965NIH HHS S10 OD018113
6 · The paper itself

Abstract

Previously, we reported that centrosomal P4.1-associated protein (CPAP/CENPJ/SAS-4) positively regulates multivesicular body (MVB) biogenesis and endocytic vesicular transport (EVT). Here, we show that CPAP is required for Rab5-to-Rab7 conversion and that the recruitment of TSG101 to early endosomes (EEs) is the molecular mechanism by which CPAP promotes MVB formation. CPAP depletion disrupts Rab7 and TSG101 recruitment to EEs and blocks endosome maturation. While endogenous CPAP co-precipitates with the ESCRT-proteins TSG101, HRS, and ALIX, exogenously expressed CPAP interacts only with TSG101. CPAP localizes to the endosomes and co-localizes with HRS and TSG101 during EVT progression. TSG101 recruitment to the endosomes, Rab5-to-Rab7 conversion, and EVT of EGFR to MVB in CPAP-depleted cells are restored by re-introduction of CPAP or overexpression of, but not endogenous, HRS. These observations show that CPAP is an ESCRT-associated protein, which functions upstream of TSG101, but in parallel to HRS, during MVB formation and EVT of cargo to the lysosomes.

Indexed as

Molecular biologyMolecular interactionMolecular network

Identifiers

PMID41630909
PMCPMC12861012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.